Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer

Erhong Meng; Lalita A. Shevde; Rajeev S. Samant

doi:10.18632/oncotarget.9803

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

This article has been retracted. Retraction in: Oncotarget. 2023; 14:669-669.

Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer

Erhong Meng, Lalita A. Shevde and Rajeev S. Samant _

PDF | HTML | How to cite

Oncotarget. 2016; 7:53984-53996. https://doi.org/10.18632/oncotarget.9803

Metrics: PDF 1939 views | HTML 3040 views | ?

Abstract

Erhong Meng1,3, Lalita A. Shevde1,2 and Rajeev S. Samant1,2

1 Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA

2 Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA

3 Beijing DOING Biomedical Technology Co. Ltd., Beijing,China

Correspondence to:

Rajeev S. Samant, email:

Keywords: DNAJB6; chaperone; cancer

Received: February 03, 2016 Accepted: May 26, 2016 Published: June 02, 2016

Abstract

DNAJB6 also known as mammalian relative of DnaJ (MRJ) encodes a highly conserved member of the DnaJ/Hsp40 family of co-chaperone proteins that function with Hsp70 chaperones. DNAJB6 is widely expressed in all tissues, with higher expression levels detected in the brain. DNAJB6 is involved in diverse cellular functions ranging from murine placental development, reducing the formation and toxicity of mis-folded protein aggregates, to self-renewal of neural stem cells. Involvement of DNAJB6 is implicated in multiple pathologies such as Huntington’s disease, Parkinson’s diseases, limb-girdle muscular dystrophy, cardiomyocyte hypertrophy and cancer. This review summarizes the important involvement of the spliced isoforms of DNAJB6 in various pathologies with a specific focus on the emerging roles of human DNAJB6 in cancer and the underlying molecular mechanisms.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9803

Publication Alerts

Reviews:

Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer

Abstract